Explore
Validate
Learn
Western blot
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- HPA038322 - Provider product page
- Provider
- Atlas Antibodies
- Proper citation
- Atlas Antibodies Cat#HPA038322, RRID:AB_10670778
- Product name
- Anti-HPD
- Antibody type
- Polyclonal
- Description
- Polyclonal Antibody against Human HPD, Gene description: 4-hydroxyphenylpyruvate dioxygenase, Alternative Gene Names: 4-HPPD, 4HPPD, GLOD3, PPD, Validated applications: IHC, WB, Uniprot ID: P32754, Storage: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 100 µl
- Concentration
- 0.1 mg/ml
- Storage
- Store at +4°C for short term storage. Long time storage is recommended at -20°C.
- Handling
- The antibody solution should be gently mixed before use.
Submitted references Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo
Oxidative Stress, Glutathione Metabolism, and Liver Regeneration Pathways Are Activated in Hereditary Tyrosinemia Type 1 Mice upon Short-Term Nitisinone Discontinuation
Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia
Ibraheim R, Tai P, Mir A, Javeed N, Wang J, RodrÃguez T, Namkung S, Nelson S, Khokhar E, Mintzer E, Maitland S, Chen Z, Cao Y, Tsagkaraki E, Wolfe S, Wang D, Pai A, Xue W, Gao G, Sontheimer E
Nature Communications 2021;12(1)
Nature Communications 2021;12(1)
Oxidative Stress, Glutathione Metabolism, and Liver Regeneration Pathways Are Activated in Hereditary Tyrosinemia Type 1 Mice upon Short-Term Nitisinone Discontinuation
Colemonts-Vroninks H, Neuckermans J, Marcelis L, Claes P, Branson S, Casimir G, Goyens P, Martens G, Vanhaecke T, De Kock J
Genes 2020;12(1):3
Genes 2020;12(1):3
Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia
Pankowicz F, Barzi M, Legras X, Hubert L, Mi T, Tomolonis J, Ravishankar M, Sun Q, Yang D, Borowiak M, Sumazin P, Elsea S, Bissig-Choisat B, Bissig K
Nature Communications 2016;7(1)
Nature Communications 2016;7(1)
No comments: Submit comment
Supportive validation
- Submitted by
- Atlas Antibodies (provider)
- Enhanced method
- Orthogonal validation
- Main image
- Experimental details
- Immunohistochemistry analysis in human liver and endometrium tissues using HPA038322 antibody. Corresponding HPD RNA-seq data are presented for the same tissues.
- Sample type
- Human
- Protocol
- Protocol
